CCDM Exam Dumps : Certified Clinical Data Manager

Thebest practicewhen implementing aprotocol amendmentthat affects CRF content or data collection timing is toupdate the eCRF completion guidelines and notify sites before implementing the change.

According to theGCDMP (Chapter: CRF Design and Data Collection), theeCRF Completion Guidelines (eCRF CG)are an essential study tool that instructs site personnel on accurate and consistent data entry. When new data elements or collection time points are added, the guidelines must berevised, version-controlled, and communicatedto all users prior to implementation to ensure sites collect and enter data correctly.

Simply relying on the revised CRF (option C) or updating the document without notification (option B) violates communication and training standards. Likewise, notifying sites without updating the documentation (option D) leaves insufficient reference material for data entry compliance.

Reference (CCDM-Verified Sources):

SCDM Good Clinical Data Management Practices (GCDMP), Chapter: CRF Design and Data Collection, Section 5.5 – Managing CRF Revisions and Site Communication

ICH E6 (R2) GCP, Section 5.18.4 – Communication of Protocol Amendments and Documentation Updates

FDA Guidance for Industry: Electronic Source Data in Clinical Investigations, Section 4.3 – Site Communication and Documentation Management

Regulatory agencies such as theFDAandICHrequire thatelectronic data be retained in a format that preserves audit trails and traceability.

While PDF images (option C) provide a static representation of data, they do not preserve theunderlying audit trail(i.e., who changed what, when, and why). TheASCII data files with corresponding audit trails(option D) provide complete transparency and comply with21 CFR Part 11andGCDMParchival standards.

Option A(storing computers) is unnecessary and impractical, andOption B(paper source documents) are site records, not system archives.

Hence,option Dis correct —ASCII data files with audit trailsmeet traceability and compliance standards.

Reference (CCDM-Verified Sources):

SCDM GCDMP, Chapter: Database Lock and Archiving, Section 5.4 – Archival Formats and Audit Trail Retention

ICH E6(R2) GCP, Section 5.5.3 – Data Integrity, Audit Trails, and Record Retention

FDA 21 CFR Part 11 – Electronic Records; Audit Trail and Retention Requirements

This event qualifies as aSerious Adverse Event (SAE)because itresulted in a prolonged hospitalization, even though the episode itself was mild.

According toICH E2AandGCDMP (Chapter: Safety Data Handling and Reconciliation), an adverse event is considered“serious”if it results in any of the following outcomes:

Death,

Life-threatening situation,

Hospitalization or prolongation of existing hospitalization,

Persistent or significant disability/incapacity, or

Congenital anomaly/birth defect.

The severity (mild, moderate, severe) describesintensity, while seriousness describesregulatory significance and medical outcome. Thus, a mild tachycardia episode leading to extended hospital stay meets theregulatory definition of an SAE.

Reference (CCDM-Verified Sources):

SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Safety Data Handling and Reconciliation, Section 5.2 – Definition and Classification of Serious Adverse Events

ICH E2A – Clinical Safety Data Management: Definitions and Standards for Expedited Reporting, Section II – Seriousness Criteria

FDA 21 CFR 312.32 – IND Safety Reporting: Serious Adverse Event Definitions